Emerging Trends to Drive Insomnia Market Growth at 6% CAGR Through 2029

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Insomnia Market Size Growth Forecast: What to Expect by 2025?
The overall scale of the insomnia market has experienced consistent expansion lately; projecting forward, its value is anticipated to ascend from five billion USD in the year 2024 to reach 5.22 billion USD by 2025, reflecting a Compound Annual Growth Rate (CAGR) of 4.3%. This upward trajectory observed during the past period stems from several factors, notably escalating stress levels among the population, the widespread occurrence of various mental health disorders, the disruption to natural sleep patterns caused by shift work and non-standard working times, greater public and clinical understanding leading to more diagnoses, and substantial intake of stimulating substances.

How Will the Insomnia Market Size Evolve and Grow by 2029?
Projections indicate vigorous expansion within the insomnia market over the near future, anticipating a valuation of six point five eight billion dollars by 2029, driven by a compound annual growth rate of six point zero percent. This forecasted upward trajectory is fueled by several factors, including the lingering effects of the worldwide health emergency, heightened public consciousness regarding proper sleep habits, a growing focus on psychological and overall well-being accompanied by governmental efforts promoting sleep health, and the impact of social factors. Key developments expected during this period encompass the rise of digital tools for tracking sleep, the utilization of cognitive behavioral therapy specifically targeting insomnia, the provision of remote consultations via telehealth for sleep issues, the incorporation of sleep wellness into standard primary medical care, and ongoing scientific investigation into entirely new treatment avenues.

View the full report here:
https://www.thebusinessresearchcompany.com/report/insomnia-global-market-report

What Drivers Are Propelling the Growth of Insomnia Market Forward?
Escalating levels of occupational strain are anticipated to fuel the expansion of the insomnia market moving ahead. This professional pressure manifests as detrimental psychological and physiological reactions arising when the requirements and burdens of a job exceed an employee's available assets, aptitudes, or expertise, with such job-related affliction frequently resulting in health deterioration, notably insomnia, which necessitates treatment modalities ranging from pharmacological interventions to cognitive-behavioral approaches, consequently propelling the sales trajectory within the insomnia sector. To illustrate this trend, data published by the American Psychological Association, a prominent US organization for psychology professionals, in October 2022 indicated that workplace stress remains a substantial concern, with a substantial 77% of workers reporting experiencing such stress within the preceding month, and furthermore, 57% documented adverse outcomes, including emotional depletion affecting 31% of respondents, conditions commonly associated with job burnout, thereby solidifying the connection between rising occupational stress and the upward momentum of the insomnia market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12120&type=smp

Which Emerging Trends Are Transforming the Insomnia Market in 2025?
A significant trend emerging within the insomnia treatment sector revolves around novel product development, compelling major players in the insomnia therapeutics arena to pursue pioneering solutions to secure their market standing. Demonstrating this, in April 2023, WELT, a medical device firm situated in Korea, secured authorization from the Ministry of Food and Drug Safety (MFDS) for its digital therapeutic apparatus designed to combat insomnia, known as WELT-I. This apparatus was designated as an innovative medical technology specifically targeting the modification of behavioral, psychological, and cognitive elements that perpetuate or exacerbate insomnia symptoms. Operating on the principles of cognitive behavioral therapy (CBT)-a primary treatment modality cited in clinical guidelines for insomnia-the device functions as software as a medical device (SaMD), enhancing sleep by implementing customized sleep scheduling, scrutinizing users' sleep disruption patterns, actively guiding patient behavior to foster better sleep hygiene, and administering eight weeks of therapeutic relaxation to mitigate anxiety and stress.

What Are the Key Segments in the Insomnia Market?
The insomniamarket covered in this report is segmented -

1) By Therapy Type: Non-Pharmacological Therapy; Pharmacological Therapy
2) By Drug Class: Anti-Depressants; Melatonin Antagonist; Benzodiazepines; Nonbenzodiazepines; Orexin Antagonist; Other Drug Classes
3) By Route Of Administration: Oral; Parenteral; Other Route Of Administration
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Subsegments:
1) By Non-Pharmacological Therapy: Cognitive Behavioral Therapy For Insomnia (CBT-I); Sleep Hygiene Education; Relaxation Techniques; Stimulus Control Therapy; Sleep Restriction Therapy
2) By Pharmacological Therapy: Prescription Medications; Over-The-Counter; Herbal Supplements

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12120&type=smp

Who Are the Key Players Shaping the Insomnia Market's Competitive Landscape?
Major companies operating in the insomnia market include Pfizer Inc., Merck & Co Inc., Sanofi S.A., GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Koninklijke Philips N.V., Viatris Inc., Astellas Pharma Inc., Sun Pharmaceutical Industries Limited, Eisai Co.Ltd., UCLA Health Insomnia Clinic, Jazz Pharmaceuticals PLC, Aurobindo Pharma Limited, Purdue Pharma LP, Cipla Inc., Dr. Reddy's Laboratories Ltd., Zydus Lifesciences Limited, Lupin Limited, Mallinckrodt Pharmaceuticals Plc., Fisher & Paykel Healthcare Corporation Limited, ResMed Inc., Sunovion Pharmaceuticals Inc., Casper Sleep Inc., Biocodex Inc., Vanda Pharmaceuticals Inc., Pernix Therapeutics Holdings Inc., SleepScore Labs, Alpha-Stim, Neurim Pharmaceuticals Ltd., NightWare Inc.

What Geographic Markets Are Powering Growth in the Insomnia Market?
North America was the largest region in the insomnia market in 2024. The regions covered in the insomnia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12120

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.